Skip to main content

Insulin Lispro Injection (Humalog) Shortage

Last Updated: April 28, 2024
Status: Current

Products Affected - Description
    • Humalog solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL vial, NDC 00002-7533-01 - discontinued
    • Humalog solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL vial, NDC 00002-7510-17 - discontinued
Reason for the Shortage
    • Lilly discontinued Humalog 3 mL vials in early-2024. Product will be distributed until inventory is depleted.
    • Sanofi has Admelog vials and Solostar Pens available.
Available Products
    • Humalog solution for injection, Lilly USA, LLC, 100 unit/mL, 10 mL vial, NDC 00002-7510-01
    • Humalog Jr. KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-7714-59
    • Humalog KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-8799-59
    • Insulin lispro Jr. KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-7752-05
    • Insulin lispro KwikPen solution for injection, Lilly USA, LLC, 100 unit/mL, 3 mL pen injector, 5 count, NDC 00002-8222-59
    • Insulin lispro solution for injection, Lilly USA, LLC, 100 unit/mL, 10 mL vial, NDC 00002-7737-01

Updated

Updated April 28, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created March 29, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer